Logo
Homepage
Explore Our Models
My Cart
Contact
Subscribe
Models
Genetically Engineered Animals
Knockout Mice
Knockout Rats
Knockin Mice
Knockin Rats
Transgenic Mice
Transgenic Rats
Model Generation Techniques
Turboknockout<sup>®</sup> Gene Targeting
ES Cell Gene Targeting
Targeted Gene Editing
Regular Transgenic
PiggyBac Transgenesis
BAC Transgenic
Research Models
HUGO-GT™ Humanized Mice
Cre Mouse Lines
Humanized Target Gene Models
Metabolic Disease Models
Ophthalmic Disease Models
Neurological Disease Models
Autoimmune Disease Models
Immunodeficient Mouse Models
Humanized Immune System Mouse Models
Oncology & Immuno-oncology Models
Covid-19 Mouse Models
MouseAtlas Model Library
Knockout Cell Line Product Catalog
Tumor Cell Line Product Catalog
AAV Standard Product Catalog
Animal Supporting Services
Breeding Services
Cryopreservation & Recovery
Phenotyping Services
BAC Modification
Custom Cell Line Models
Induced Pluripotent Stem Cells (iPSCs)
Knockout Cell Lines
Knockin Cell Lines
Point Mutation Cell Lines
Overexpression Cell Lines
Virus Packaging
Adeno-associated Virus (AAV) Packaging
Lentivirus Packaging
Adenovirus Packaging
CRO Services
By Therapeutic Area
Oncology
Ophthalmology
Neuroscience
Metabolic & Cardiovascular Diseases
Autoimmune & Inflammatory
By Drug Type
AI-Powered AAV Discovery
Gene Therapy
Oligonucleotide Therapy
Antibody Therapy
Cell Immunotherapy
Resources
Promotion
Events & Webinars
Newsroom
Blogs & Insights
Resource Vault
Reference Databases
Peer-Reviewed Citations
Rare Disease Data Center
AbSeek
Cell iGeneEditor™ System
OriCell
Quality
Facility Overview
Animal Health & Welfare
Health Reports
About Us
Corporate Overview
Our Partners
Careers
Contact Us
Login
Request a Product Quote
Select products from our catalogs and submit your request. Our team will get back to you with detailed information.
Full Name
Email
Phone Number
Organization
Job Role
Country
Catalog Type
Product Name
Additional Comments
Cyagen values your privacy. We’d like to keep you informed about our latest offerings and insights. Your preferences:
You may unsubscribe from these communications at any time. See our Privacy Policy for details on opting out and data protection.
By clicking the button below, you consent to allow Cyagen to store and process the personal information submitted in this form to provide you the content requested.
C57BL/6JCya-Amotl2em1flox/Cya
Common Name:
Amotl2-flox
Product ID:
S-CKO-18073
Background:
C57BL/6JCya
Product Type
Age
Genotype
Sex
Quantity
Price:
Contact for Pricing
Basic Information
Strain Name
Amotl2-flox
Strain ID
CKOCMP-56332-Amotl2-B6J-VB
Gene Name
Amotl2
Product ID
S-CKO-18073
Gene Alias
Lccp; MASCOT; mKIAA0989
Background
C57BL/6JCya
NCBI ID
56332
Modification
Conditional knockout
Chromosome
9
Phenotype
MGI:1929286
Document
Click here to download >>
Application
--
More
Rare Disease Data Center >>
Note
Note: When using this mouse strain in a publication, please cite “C57BL/6JCya-Amotl2em1flox/Cya mice (Catalog S-CKO-18073) were purchased from Cyagen.”
Strain Description
Ensembl Number
ENSMUST00000035121
NCBI RefSeq
NM_019764
Target Region
Exon 3
Size of Effective Region
~2.2 kb
Detailed Document
Click here to download >>
Overview of Gene Research
Amotl2, short for angiomotin-like 2, is a member of the motin family of angiostatin-binding proteins. It serves as a scaffold protein that integrates external and internal stimuli to regulate various signaling pathways [1,2,5]. It is involved in pathways such as the Wnt/β -catenin, Hippo, and may be related to the regulation of protein phosphatase 2A (PP2A) complex-associated signaling [3,4,6]. Amotl2 plays a crucial role in many cellular processes including cell differentiation, migration, angiogenesis, and contact inhibition, and thus is important for normal biological development and disease-related processes [1,4]. Genetic models, like knockout (KO) or conditional knockout (CKO) mouse models, can be valuable tools to study its function.

In glioma, AMOTL2-knockdown promotes the proliferation, migration, and invasion of glioma cells by regulating β-catenin nuclear localization. High AMOTL2 expression in glioma patients is associated with a higher survival rate [3]. In non-small cell lung cancer cells, upregulation of AMOTL2 leads to cell proliferation delay as it inhibits JUN Thr239 dephosphorylation by binding PPP2R2A [6]. In airway smooth muscle cells, AMOTL2 restrains TGF-β1-induced proliferation and extracellular matrix deposition via down-regulation of YAP1 activation [7]. The endothelial deficit of AmotL2 in mice fed a normal diet provokes a pro-inflammatory response and abdominal aortic aneurysms (AAAs), and in human AAA samples, there is a negative correlation between AmotL2 and aortic intima inflammation [8]. The circadian gene ARNTL2 promotes nasopharyngeal carcinoma invasiveness and metastasis through suppressing the AMOTL2-LATS-YAP pathway [9]. In luminal breast cancer, MAGI1 acts as a tumor-suppressor by inhibiting an AMOTL2/p38 stress pathway [10].

In conclusion, AmotL2 is a significant regulator in multiple biological processes. Through model-based research, its role in diseases such as glioma, non-small cell lung cancer, airway-related conditions, aortic diseases, nasopharyngeal carcinoma, and luminal breast cancer has been revealed. These findings enhance our understanding of disease mechanisms and may provide potential therapeutic targets.

References:
1. Rotoli, Deborah, Díaz-Flores, Lucio, Gutiérrez, Ricardo, Ávila, Julio, Martín-Vasallo, Pablo. 2021. AmotL2, IQGAP1, and FKBP51 Scaffold Proteins in Glioblastoma Stem Cell Niches. In The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society, 70, 9-16. doi:10.1369/00221554211025480. https://pubmed.ncbi.nlm.nih.gov/34165350/
2. González-Fernández, Rebeca, González-Nicolás, María Ángeles, Morales, Manuel, Lázaro, Alberto, Martín-Vasallo, Pablo. 2022. FKBP51, AmotL2 and IQGAP1 Involvement in Cilastatin Prevention of Cisplatin-Induced Tubular Nephrotoxicity in Rats. In Cells, 11, . doi:10.3390/cells11091585. https://pubmed.ncbi.nlm.nih.gov/35563891/
3. Chen, Xingjie, Lu, Yalin, Guo, Gaochao, Jin, Xun, Huang, Qiang. 2021. AMOTL2‑knockdown promotes the proliferation, migration and invasion of glioma by regulating β‑catenin nuclear localization. In Oncology reports, 46, . doi:10.3892/or.2021.8090. https://pubmed.ncbi.nlm.nih.gov/34036399/
4. Hwang, Daehee, Kim, Miju, Kim, Soyeon, Kang, Ho-Chul, Lim, Dae-Sik. 2021. AMOTL2 mono-ubiquitination by WWP1 promotes contact inhibition by facilitating LATS activation. In Life science alliance, 4, . doi:10.26508/lsa.202000953. https://pubmed.ncbi.nlm.nih.gov/34404733/
5. Rotoli, Deborah, Morales, Manuel, Maeso, María-Del-C, van Noorden, Cornelis J F, Martín-Vasallo, Pablo. 2019. IQGAP1, AmotL2, and FKBP51 Scaffoldins in the Glioblastoma Microenvironment. In The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society, 67, 481-494. doi:10.1369/0022155419833334. https://pubmed.ncbi.nlm.nih.gov/30794467/
6. Cui, Renjie, Jiang, Nan, Zhang, Meiqin, Ma, Duan, Zhang, Jin. 2020. AMOTL2 inhibits JUN Thr239 dephosphorylation by binding PPP2R2A to suppress the proliferation in non-small cell lung cancer cells. In Biochimica et biophysica acta. Molecular cell research, 1868, 118858. doi:10.1016/j.bbamcr.2020.118858. https://pubmed.ncbi.nlm.nih.gov/32950569/
7. Fang, Ping, Deng, Wen-Jing, Fan, Na, Pan, Jian-Li, Yang, Shuan-Ying. 2021. AMOTL2 restrains transforming growth factor-β1-induced proliferation and extracellular matrix deposition of airway smooth muscle cells via the down-regulation of YAP1 activation. In Environmental toxicology, 36, 2225-2235. doi:10.1002/tox.23336. https://pubmed.ncbi.nlm.nih.gov/34323359/
8. Zhang, Yuanyuan, Zhang, Yumeng, Hutterer, Evelyn, Eriksson, Per, Holmgren, Lars. 2023. The VE-cadherin/AmotL2 mechanosensory pathway suppresses aortic inflammation and the formation of abdominal aortic aneurysms. In Nature cardiovascular research, 2, 629-644. doi:10.1038/s44161-023-00298-8. https://pubmed.ncbi.nlm.nih.gov/39195920/
9. Zou, Wenqing, Lei, Yiming, Ding, Cong, Liu, Na, Mao, Yanping. 2024. The circadian gene ARNTL2 promotes nasopharyngeal carcinoma invasiveness and metastasis through suppressing AMOTL2-LATS-YAP pathway. In Cell death & disease, 15, 466. doi:10.1038/s41419-024-06860-x. https://pubmed.ncbi.nlm.nih.gov/38956029/
10. Kantar, Diala, Mur, Emilie Bousquet, Mancini, Maicol, Heron-Milhavet, Lisa, Djiane, Alexandre. 2021. MAGI1 inhibits the AMOTL2/p38 stress pathway and prevents luminal breast tumorigenesis. In Scientific reports, 11, 5752. doi:10.1038/s41598-021-85056-1. https://pubmed.ncbi.nlm.nih.gov/33707576/
Quality Control Standard
Sperm Test

Pre-cryopreservation: Measurement of sperm concentration, determination of sperm viability.

Post-cryopreservation: A vial of cryopreserved sperms is selected for in-vitro fertilization from each batch.

Environmental Standards:SPF
Available Region:Global
Source:Cyagen
Model Library
Model Library
Resources
Resources
Animal Quality
Animal Quality
Get Support
Get Support
Address:
2255 Martin Avenue, Suite E Santa Clara, CA 95050-2709, US
Tel:
800-921-8930 (8-6pm PST)
+1408-963-0306 (lnt’l)
Fax:
408-969-0338
Email:
animal-service@cyagen.com
service@cyagen.us
CRO Services
OncologyOphthalmologyNeuroscienceMetabolic & CardiovascularAutoimmune & InflammatoryGene TherapyAntibody Therapy
About Us
Corporate OverviewOur PartnersCareersContact Us
Social Media
Disclaimer: Pricing and availability of our products and services vary by region. Listed prices are applicable to the specific countries. Please contact us for more information.
Copyright © 2025 Cyagen. All rights reserved.
Privacy Policy
Site Map
Stay Updated with the Latest from Cyagen
Get the latest news on our research models, CRO services, scientific resources, and special offers—tailored to your research needs and delivered straight to your inbox.
Full Name
Email
Organization
Country
Areas of Interest